Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bláfar is a biotechnology company specializing in the development and supply of high-quality, functionalized biopolymers, with a primary focus on hyaluronic acid derivatives. The company provides researchers and pharmaceutical developers with click-chemistry ready materials that enable the creation of advanced hydrogels, drug delivery systems, and tissue engineering scaffolds. By offering standardized, pre-functionalized polymers, Bláfar simplifies the complex chemical modification process, allowing for more reproducible and scalable biomedical research. Their product portfolio includes various functional groups such as azides, alkynes, and methacrylates, catering to diverse cross-linking and conjugation needs. The company's technology is rooted in advanced polymer chemistry, facilitating the development of next-generation medical devices and therapeutic delivery vehicles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bláfar.